Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Ortiz, Cristian M ^a   Ito, Tetsuo ^b   Hashimoto, Yosuke ^c   Nagayama, Satoshi ^d   Iwai, Akira ^d   Tsunoda, Shigeru ^d   Sato, Fumiaki ^d   Martorell, Miguel ^a   Garcia, Jose A ^a   Perez, Ana ^a   Shimada, Yutaka ^e  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Sugita Genpaku Memorial Obama Municipal Hospital   (Japan)

^c SHIZUOKA CANCER CENTER   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CARRIER PROTEIN; CASPASE; COLLAGEN; CYSTEINE PROTEINASE INHIBITOR; FASCIN; PEPTIDE CHLOROMETHYL KETONE; SMALL INTERFERING RNA;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL ADHESION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG SCREENING; ESOPHAGUS TUMOR; GENETIC TRANSFECTION; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE; TUMOR VOLUME;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CASPASES; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; CYSTEINE PROTEINASE INHIBITORS; ESOPHAGEAL NEOPLASMS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROFILAMENT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953676348     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-41     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Visser BC, Venook AP, Patti MG. Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. Surg Oncol 2003, 12(1):1-7. 10.1016/S0960-7404(02)00072-5, 12689665.
3. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003, 349(23):2241-2252. 10.1056/NEJMra035010, 14657432.
4. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993, 71(4):1368-1383. 10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L, 8435813.
5. Partin AW, Schoeniger JS, Mohler JL, Coffey DS. Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci USA 1989, 86(4):1254-1258. 10.1073/pnas.86.4.1254, 286666, 2919174.
6. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001, 411(6835):375-379. 10.1038/35077241, 11357145.
7. Otto JJ. Actin-bundling proteins. Curr Opin Cell Biol 1994, 6(1):105-109. 10.1016/0955-0674(94)90123-6, 8167015.
8. Tilney LG, Connelly PS, Vranich KA, Shaw MK, Guild GM. Why are two different cross-linkers necessary for actin bundle formation in vivo and what does each cross-link contribute?. J Cell Biol 1998, 143(1):121-133. 10.1083/jcb.143.1.121, 2132811, 9763425.
9. Matsudaira P. Actin crosslinking proteins at the leading edge. Semin Cell Biol 1994, 5(3):165-174. 10.1006/scel.1994.1021, 7919230.
10. Kureishy N, Sapountzi V, Prag S, Anilkumar N, Adams JC. Fascins, and their roles in cell structure and function. Bioessays 2002, 24(4):350-361. 10.1002/bies.10070, 11948621.
11. Bryan J, Edwards R, Matsudaira P, Otto J, Wulfkuhle J. Fascin, an echinoid actin-bundling protein, is a homolog of the Drosophila singed gene product. Proc Natl Acad Sci USA 1993, 90(19):9115-9119. 10.1073/pnas.90.19.9115, 47512, 8415664.
12. Al-Alwan MM, Rowden G, Lee TD, West KA. Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol 2001, 166(1):338-345.
13. Cohan CS, Welnhofer EA, Zhao L, Matsumura F, Yamashiro S. Role of the actin bundling protein fascin in growth cone morphogenesis: localization in filopodia and lamellipodia. Cell Motil Cytoskeleton 2001, 48(2):109-120. 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G, 11169763.
14. Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, Matsumura F, Kieff E, Birkenbach M. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J Virol 1994, 68(11):7320-7328. 237173, 7933116.
15. Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW, Yu D, Mooney EE, McCrea PD. C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 2000, 19(42):4864-4875. 10.1038/sj.onc.1203838, 11039904.
16. Grothey A, Hashizume R, Sahin AA, McCrea PD. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000, 83(7):870-873. 10.1054/bjoc.2000.1395, 2374674, 10970687.
17. Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000, 18(1):83-88. 10.1023/A:1026596609969, 11206843.
18. Goncharuk VN, Ross JS, Carlson JA. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002, 29(7):430-438. 10.1034/j.1600-0560.2002.290708.x, 12139639.
19. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002, 160(4):1239-1249. 1867224, 11943709.
20. Maitra A, Iacobuzio-Donahue C, Rahman A, Sohn TA, Argani P, Meyer R, Yeo CJ, Cameron JL, Goggins M, Kern SE, Ashfaq R, Hruban RH, Wilentz RE. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 2002, 118(1):52-59. 10.1309/3PAM-P5WL-2LV0-R4EG, 12109856.
21. Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y, Maehara Y, Tsuneyoshi M. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: Immunohistochemical and molecular analysis. Hum Pathol 2009, 402:174-80.
22. Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer 2005, 103(6):1154-1164. 10.1002/cncr.20901, 15712207.
23. Pelosi G, Pasini F, Fraggetta F, Pastorino U, Iannucci A, Maisonneuve P, Arrigoni G, De Manzoni G, Bresaola E, Viale G. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 2003, 42(2):203-213. 10.1016/S0169-5002(03)00294-0, 14568688.
24. Shimada Y, Maeda M, Watanabe G, Yamasaki S, Komoto I, Kaganoi J, Kan T, Hashimoto Y, Imoto I, Inazawa J, Imamura M. Cell culture in esophageal squamous cell carcinoma and the association with molecular markers. Clin Cancer Res 2003, 9(1):243-249.
25. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z, Li E. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006, 59(9):958-964. 10.1136/jcp.2005.032730, 1860492, 16524962.
26. Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M, Shimada Y. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005, 11(7):2597-2605. 10.1158/1078-0432.CCR-04-1378, 15814639.
27. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004, 67(3-4):262-270. 10.1159/000081327, 15557788.
28. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 1993, 15(3):532-4-536-7.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162(1):156-159. 10.1016/0003-2697(87)90021-2, 2440339.
30. Tao YS, Edwards RA, Tubb B, Wang S, Bryan J, McCrea PD. beta-Catenin associates with the actin-bundling protein fascin in a noncadherin complex. J Cell Biol 1996, 134(5):1271-1281. 10.1083/jcb.134.5.1271, 2120989, 8794867.
31. Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, Xie YM, Yang ZM, Niu YD, Shen ZY, Li EM. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 2005, 337(1):355-362. 10.1016/j.bbrc.2005.09.055, 16185662.
32. Valentijn AJ, Zouq N, Gilmore AP. Anoikis. Biochem Soc Trans 2004, 32(Pt3):421-425. 10.1042/BST0320421, 15157151.
33. Chen CY, Chiou SH, Huang CY, Jan CI, Lin SC, Tsai ML, Lo JF. Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model. J Biomed Sci 2009, 161:100.
34. Kulluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401. 10.1038/nrc1877, 16572188.
35. Ito TK, Ishii G, Chiba H, Ochiai A. The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 2007, 26:7194-203. 10.1038/sj.onc.1210535, 17525740.
36. Saitoh O, Mitsutake N, Nakayama T, Nagayama Y. Fibroblast-mediated in vivo and in vitro growth promotion of tumorigenic rat thyroid carcinoma cells but not normal Fisher rat thyroid follicular cells. Thyroid 2009, 19:735-42. 10.1089/thy.2009.0017, 19485776.
37. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M, Adams JC. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003, 162(1):69-80. 1851132, 12507891.
38. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124(4):619-626. 10.1083/jcb.124.4.619, 2119917, 8106557.
39. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2000, 2(5):249-256. 10.1038/35010517, 10806474.
40. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET, Cance WG. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995, 55(13):2752-2755.
41. Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ, Cance WG. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996, 3(1):100-105. 10.1007/BF02409059, 8770310.
42. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 2003, 163(4):847-857. 10.1083/jcb.200308162, 2173691, 14623871.
43. Kamarajan P, Kapila YL. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK. Apoptosis 2007, 12(12):2221-2231. 10.1007/s10495-007-0138-9, 17879163.
44. Li W, Duzgun A, Sumpio BE, Basson MD. Integrin and FAK-mediated MAPK activation is required for cyclic strain mitogenic effects in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 2001, 280(1):G75-87.
45. Wang Z, Yang H, Tachado SD, Capo-Aponte JE, Bildin VN, Koziel H, Reinach PS. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells. Invest Ophthalmol Vis Sci 2006, 47(12):5267-5275. 10.1167/iovs.06-0642, 17122112.
46. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, Thannickal VJ. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 2007, 19(4):761-771. 10.1016/j.cellsig.2006.10.001, 1820832, 17113264.
47. Herzhoff K, Sollberg S, Huerkamp C, Krieg T, Eckes B. Fibroblast expression of collagen integrin receptors alpha1beta1 and alpha2beta1 is not changed in systemic scleroderma. Br J Dermatol 1999, 141(2):218-223. 10.1046/j.1365-2133.1999.02968.x, 10468791.
48. Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL. Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 2006, 66(10):5487-5494. 10.1158/0008-5472.CAN-06-0100, 16707478.
49. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002, 109(8):987-991. 150951, 11956233.